
Tofacidax 11mg Tablet ER
Marketer
Daxia Healthcare
Salt Composition
Tofacitinib (11mg)
Overview Tofacidax 11mg Tablet ER
Arthalon 11mg Extended-Release Tablets are indicated for managing moderate to severe rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and ulcerative colitis. This medication alleviates joint pain, tenderness, and swelling by suppressing inflammation, and also helps retard the progression of bone and joint deterioration. Arthalon 11mg Extended-Release Tablets may be administered alone or in conjunction with other medications. These tablets can be ingested with or without food, ideally at the same time daily. Dosage is determined by your individual health status and concurrent medications; always adhere to your physician's instructions. Discontinue use only under your doctor's guidance, as abrupt cessation may exacerbate your condition. Commonly reported adverse effects include upper respiratory infections, headache, diarrhea, and nasopharyngitis. Less frequent, but potentially serious, side effects such as blood clots and gastrointestinal perforations necessitate immediate medical attention. Report any concerns regarding side effects to your doctor promptly. Pre-treatment blood work may be required, and initiation of treatment is contraindicated in the presence of any infection. Consult your doctor before commencing therapy if you have a history of, or currently experience, tuberculosis, herpes zoster, hepatic or renal impairment, hepatitis B or C, or pulmonary or venous thromboembolism. Arthalon 11mg Extended-Release Tablets may increase susceptibility to infections or worsen existing ones; therefore, minimize contact with individuals exhibiting contagious illnesses (e.g., varicella, measles, influenza). This medication is not suitable for pediatric patients under 18 years of age, and its use during pregnancy or breastfeeding should only be considered if the potential benefits outweigh the risks as determined by your physician. Regular check-ups with your doctor may be necessary.
Primary Ingredients of Tofacidax 11mg Tablet ER
The provided text is "undefined," which lacks meaning and cannot be rephrased.
Uses of Tofacidax 11mg Tablet ER
Managing rheumatoid, psoriatic, and ankylosing spondylitis arthritis, plus ulcerative colitis.
Major Benefits of Tofacidax 11mg Tablet ER:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. The 11mg extended-release Tofacidax tablet should be swallowed whole; do not crush, chew, or break it. While you may consume it with or without food, consistent timing is recommended.
Common Side effects of Tofacidax 11mg Tablet ER:
- Upper respiratory tract infection
- Headache
- Diarrhea
- Nasopharyngitis (inflammation of the throat and nasal passages)
How to use Tofacidax 11mg Tablet ER:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Swallow the Tofacidax 11mg Extended-Release tablet whole; do not crush, chew, or break it. While this medication can be taken with or without food, consistency is key – aim for the same time each day.
How Tofacidax 11mg Tablet ER works:
Tofacidax 11mg Extended-Release tablets are a Janus kinase (JAK) inhibitor. Their mechanism of action involves suppressing Janus kinase enzyme activity, thereby reducing immune system activation and inflammation characteristic of rheumatic conditions and ulcerative colitis.
SAFETY ADVICE
AlcoholSAFE
Concurrent use of Tofacidax 11mg Extended-Release Tablets and alcohol presents no known adverse reactions.
PregnancyCONSULT YOUR DOCTOR
Extended-release Tofacidax 11mg tablets might pose pregnancy risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the potential advantages against any risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Tofacidax 11mg tablets are likely unsafe for breastfeeding mothers. Available human data indicates potential transfer of the medication into breast milk, posing a risk to the infant.
DrivingSAFE
Extended-release Tofacidax 11mg tablets typically do not impair driving ability.
KidneyCAUTION
Patients with severe kidney impairment should exercise caution when using Tofacidax 11mg Extended-Release Tablets. Dosage modification for Tofacidax 11mg Extended-Release Tablets may be necessary. Physician consultation is advised.
LiverCAUTION
Extended-release Tofacidax 11mg tablets require careful administration in individuals with advanced hepatic impairment. Dosage modification of Tofacidax 11mg extended-release tablets may be necessary. Physician consultation is advised.
What if you forget to take Tofacidax 11mg Tablet ER :
Should you forget a Tofacidax 11mg Extended-Release tablet, take it immediately. If your next dose is imminent, however, omit the missed dose and resume your usual dosing regimen. Never take more than the prescribed dose.
Facts to Know About Tofacidax 11mg Tablet ER
| Label | Value |
|---|---|
| Chemical Type | Pyrrolopyrimidine Compound |
| Developing Habits | No. |
| Type of Therapy | Pain Relievers |
| Behavior Class | JAK inhibitors |
